FDA Details Problems at Plant Behind Recalled Baby Formula March 24, 2022 By Matthew Perrone WASHINGTON (AP) — Baby formula maker Abbott failed to maintain sanitary conditions and procedures at the Michigan manufacturing plant recently...
Dollar Tree Gets Grand Jury Subpoena Over Rodent Infestation March 15, 2022 By Jordyn Holman Dollar Tree Inc. was issued a federal grand jury subpoena related to a pest and sanitation issue, according to a...
Troubling Questions Follow Closure of Sprawling Pain Clinic Chain February 22, 2022 By Anna Maria Barry-Jester and Jenny Gold HANFORD, Calif. — On May 13 of last year, the cellphones of thousands of California residents undergoing treatment for chronic...
J&J Kept Quiet on Popular Diabetes Drug as Red Flags Multiplied December 8, 2021 RARITAN, New Jersey–Gathered for an emergency meeting, the Johnson & Johnson drug safety team painted an alarming scene: People taking...
Philips Investigates Number of Complaints in FDA Ventilator Report November 24, 2021 AMSTERDAM — Dutch medical equipment maker Philips on Wednesday said U.S. regulators might have overestimated the number of safety issues...
Opioid Trial Against CVS, Walgreens, Walmart Winding Down November 17, 2021 CLEVELAND (AP) — Three retail pharmacy chains failed to follow government guidelines to make sure pain pills weren’t flooding Ohio...
COVID-19 Vaccine Approval is ‘Seismic’ Shift For Legality Of Mandates, Experts Say August 25, 2021 By Tom Hals Formal U.S approval of the Pfizer Inc /BioNTech SE COVID-19 vaccine will make it nearly impossible to successfully challenge mandates...
Sunscreen Concerns Escalate as Another Potential Carcinogen Found August 9, 2021 By Anna Edney Researchers asked U.S. regulators to pull some sunscreens from the market, including brands such as Coppertone, Banana Boat and Neutrogena,...
Judge Tosses Houston Hospital Workers’ Lawsuit Over Vaccine Requirement June 15, 2021 By Karen Freifeld A U.S. federal judge has dismissed a lawsuit brought by 117 workers at a Texas hospital over its requirement that...
Bristol-Myers Is Sued for $6.4 Billion Over Delayed Cancer Drug June 3, 2021 By Jonathan Stempel NEW YORK — Bristol Myers Squibb Co was sued for $6.4 billion on Thursday for allegedly delaying its Breyanzi cancer...